Towa Pharmaceutical Co., Ltd. (4553.T)
JPY 2808.0
(2.3%)
JPY 2808.0
(2.3%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 17.64 Billion JPY | 220.06% |
| 2022 | 5.51 Billion JPY | -71.29% |
| 2021 | 19.2 Billion JPY | -3.6% |
| 2020 | 19.92 Billion JPY | 23.42% |
| 2019 | 16.14 Billion JPY | 1.1% |
| 2018 | 15.96 Billion JPY | 37.15% |
| 2017 | 11.64 Billion JPY | 69.5% |
| 2016 | 6.86 Billion JPY | -38.31% |
| 2015 | 11.13 Billion JPY | 0.26% |
| 2014 | 11.1 Billion JPY | 44.11% |
| 2013 | 7.7 Billion JPY | -0.22% |
| 2012 | 7.72 Billion JPY | -15.22% |
| 2011 | 9.1 Billion JPY | -5.66% |
| 2010 | 9.65 Billion JPY | 24.66% |
| 2009 | 7.74 Billion JPY | 20.86% |
| 2008 | 6.4 Billion JPY | 21.23% |
| 2007 | 5.28 Billion JPY | 19.67% |
| 2006 | 4.41 Billion JPY | 84.24% |
| 2005 | 2.39 Billion JPY | -12.34% |
| 2004 | 2.73 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 5.67 Billion JPY | 27.69% |
| 2023 Q1 | 4.09 Billion JPY | 2428.4% |
| 2023 FY | 17.64 Billion JPY | 220.06% |
| 2023 Q4 | 4.44 Billion JPY | -28.37% |
| 2023 Q3 | 6.2 Billion JPY | 113.31% |
| 2023 Q2 | 2.9 Billion JPY | -29.03% |
| 2022 FY | 5.51 Billion JPY | -71.29% |
| 2022 Q4 | 162 Million JPY | -92.4% |
| 2022 Q2 | 1.28 Billion JPY | -34.02% |
| 2022 Q1 | 1.94 Billion JPY | -12.3% |
| 2022 Q3 | 2.13 Billion JPY | 66.56% |
| 2021 Q4 | 2.21 Billion JPY | -66.89% |
| 2021 Q2 | 4.23 Billion JPY | -30.42% |
| 2021 Q3 | 6.68 Billion JPY | 57.91% |
| 2021 Q1 | 6.08 Billion JPY | 18.38% |
| 2021 FY | 19.2 Billion JPY | -3.6% |
| 2020 Q2 | 4.21 Billion JPY | -7.83% |
| 2020 Q1 | 4.57 Billion JPY | 126.13% |
| 2020 FY | 19.92 Billion JPY | 23.42% |
| 2020 Q4 | 5.13 Billion JPY | -14.44% |
| 2020 Q3 | 6 Billion JPY | 42.55% |
| 2019 Q1 | 5.2 Billion JPY | 29.84% |
| 2019 Q3 | 4.9 Billion JPY | 22.32% |
| 2019 Q2 | 4 Billion JPY | -23.04% |
| 2019 FY | 16.14 Billion JPY | 1.1% |
| 2019 Q4 | 2.02 Billion JPY | -58.79% |
| 2018 Q1 | 3.5 Billion JPY | 43.86% |
| 2018 Q2 | 2.42 Billion JPY | -30.74% |
| 2018 FY | 15.96 Billion JPY | 37.15% |
| 2018 Q4 | 4.01 Billion JPY | -33.49% |
| 2018 Q3 | 6.03 Billion JPY | 148.84% |
| 2017 Q1 | 2.37 Billion JPY | 74.45% |
| 2017 Q4 | 2.43 Billion JPY | -41.12% |
| 2017 FY | 11.64 Billion JPY | 69.5% |
| 2017 Q3 | 4.13 Billion JPY | 52.92% |
| 2017 Q2 | 2.7 Billion JPY | 13.72% |
| 2016 Q3 | 3.18 Billion JPY | 223.25% |
| 2016 Q2 | 985 Million JPY | -26.38% |
| 2016 FY | 6.86 Billion JPY | -38.31% |
| 2016 Q1 | 1.33 Billion JPY | -39.59% |
| 2016 Q4 | 1.36 Billion JPY | -57.22% |
| 2015 Q3 | 3.39 Billion JPY | 35.34% |
| 2015 Q1 | 3.01 Billion JPY | 20.82% |
| 2015 FY | 11.13 Billion JPY | 0.26% |
| 2015 Q4 | 2.21 Billion JPY | -34.8% |
| 2015 Q2 | 2.51 Billion JPY | -16.67% |
| 2014 Q1 | 2.09 Billion JPY | 59.14% |
| 2014 FY | 11.1 Billion JPY | 44.11% |
| 2014 Q4 | 2.49 Billion JPY | -43.71% |
| 2014 Q3 | 4.42 Billion JPY | 112.52% |
| 2014 Q2 | 2.08 Billion JPY | -0.71% |
| 2013 Q4 | 1.31 Billion JPY | -59.64% |
| 2013 FY | 7.7 Billion JPY | -0.22% |
| 2013 Q1 | 1.78 Billion JPY | 84.31% |
| 2013 Q2 | 1.33 Billion JPY | -25.36% |
| 2013 Q3 | 3.26 Billion JPY | 145.16% |
| 2012 Q1 | 2.46 Billion JPY | 31.12% |
| 2012 Q2 | 1.9 Billion JPY | -22.76% |
| 2012 FY | 7.72 Billion JPY | -15.22% |
| 2012 Q3 | 2.38 Billion JPY | 25.26% |
| 2012 Q4 | 969 Million JPY | -59.37% |
| 2011 Q2 | 2.28 Billion JPY | -3.46% |
| 2011 Q1 | 2.37 Billion JPY | 0.34% |
| 2011 Q3 | 2.57 Billion JPY | 12.37% |
| 2011 Q4 | 1.88 Billion JPY | -26.88% |
| 2011 FY | 9.1 Billion JPY | -5.66% |
| 2010 Q4 | 2.36 Billion JPY | -17.04% |
| 2010 Q2 | 2.56 Billion JPY | 41.46% |
| 2010 Q1 | 1.81 Billion JPY | 2.95% |
| 2010 FY | 9.65 Billion JPY | 24.66% |
| 2010 Q3 | 2.84 Billion JPY | 10.82% |
| 2009 Q3 | 2.21 Billion JPY | 25.84% |
| 2009 FY | 7.74 Billion JPY | 20.86% |
| 2009 Q1 | 1.99 Billion JPY | 6.76% |
| 2009 Q4 | 1.76 Billion JPY | -20.28% |
| 2009 Q2 | 1.75 Billion JPY | -11.64% |
| 2008 Q4 | 1.86 Billion JPY | -0.17% |
| 2008 Q1 | 1.08 Billion JPY | 0.0% |
| 2008 FY | 6.4 Billion JPY | 21.23% |
| 2008 Q3 | 1.86 Billion JPY | 20.26% |
| 2008 Q2 | 1.55 Billion JPY | 43.07% |
| 2007 FY | 5.28 Billion JPY | 19.67% |
| 2006 FY | 4.41 Billion JPY | 84.24% |
| 2005 FY | 2.39 Billion JPY | -12.34% |
| 2004 FY | 2.73 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 5.11 Billion JPY | -245.159% |
| Takeda Pharmaceutical Company Limited | 214.07 Billion JPY | 91.756% |
| Sumitomo Pharma Co., Ltd. | -354.19 Billion JPY | 104.983% |
| Shionogi & Co., Ltd. | 171.46 Billion JPY | 89.707% |
| Wakamoto Pharmaceutical Co.,Ltd. | -195.51 Million JPY | 9126.602% |
| Nippon Shinyaku Co., Ltd. | 31.38 Billion JPY | 43.771% |
| Kaken Pharmaceutical Co., Ltd. | 9.51 Billion JPY | -85.515% |
| Eisai Co., Ltd. | 53.4 Billion JPY | 66.956% |
| Morishita Jintan Co., Ltd. | 716 Million JPY | -2364.804% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.16 Billion JPY | -34.032% |
| Mochida Pharmaceutical Co., Ltd. | 5.8 Billion JPY | -204.119% |
| Fuso Pharmaceutical Industries,Ltd. | 1.96 Billion JPY | -798.574% |
| Nippon Chemiphar Co., Ltd. | -494 Million JPY | 3672.47% |
| Tsumura & Co. | 20.01 Billion JPY | 11.839% |
| Kissei Pharmaceutical Co., Ltd. | 4.01 Billion JPY | -339.333% |
| Torii Pharmaceutical Co., Ltd. | 5.03 Billion JPY | -250.437% |
| Fuji Pharma Co., Ltd. | 3.85 Billion JPY | -357.439% |
| Zeria Pharmaceutical Co., Ltd. | 9.71 Billion JPY | -81.626% |
| KYORIN Holdings, Inc. | 6.01 Billion JPY | -193.497% |
| Taiko Pharmaceutical Co.,Ltd. | -3.07 Billion JPY | 673.173% |
| Daito Pharmaceutical Co.,Ltd. | 3.89 Billion JPY | -353.21% |
| SymBio Pharmaceuticals Limited | -811.66 Million JPY | 2274.288% |
| MedRx Co., Ltd | -933 Million JPY | 1991.533% |
| Mizuho Medy Co.,Ltd. | 5.15 Billion JPY | -242.547% |
| Solasia Pharma K.K. | -1.13 Billion JPY | 1649.429% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 844.641% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 6.5 Billion JPY | -171.508% |
| Sawai Group Holdings Co., Ltd. | 18.88 Billion JPY | 6.555% |
| Cyfuse Biomedical K.K. | -697.43 Million JPY | 2630.408% |
| Toho Holdings Co., Ltd. | 19.33 Billion JPY | 8.706% |
| Koa Shoji Holdings Co.,Ltd. | 4.38 Billion JPY | -302.71% |